Indian Fluoxetine Exporters: Complete Supplier Ranking with Market Share — 253 Manufacturers (2026) — TransData Nexus

Q: Who is the largest fluoxetine supplier from India?

SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED is the largest fluoxetine exporter from India with a 48.4% market share and export value of $113.8M.

Q: How many fluoxetine suppliers are there in India?

There are 253 active fluoxetine exporters in India, collectively shipping $235.3M worth of fluoxetine across 3,702 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top fluoxetine suppliers from India?

The top 5 fluoxetine suppliers from India — SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, MICRO LABS LIMITED, AUROBINDO PHARMA LTD, TORRENT PHARMACEUTICALS LTD — together control 80.4% of total fluoxetine export value from India.

Suresh Sormare

Fluoxetine

India Pharmaceutical Trade Intelligence

$235.3M253 Suppliers101 CountriesHS 30049099

ExportsIndia → UNITED STATES65.6%India → CANADA12.9%

ImportsUNITED KINGDOM → India$6.7B GERMANY → India$738.6K

#1 Supplier: SIDMAK LABORATORIES

Fluoxetine Suppliers from India (2026) — 253 Exporters, $235.3M Market | TransData Nexus | TransData Nexus

Who Exports Fluoxetine from India — 253 Suppliers Behind a $235.3M Market

India's fluoxetine export market is supplied by 253 active exporters who collectively shipped $235.3M across 3,702 shipments. SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED leads with a 48.4% market share, followed by INTAS PHARMACEUTICALS LIMITED and MICRO LABS LIMITED. The top 5 suppliers together control 80.4% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Fluoxetine Suppliers & Exporters — 253 manufacturers, $235.3M export market, top destinations and formulations — Fluoxetine supplier data — 253 exporters · $235.3M market · 3,702 shipmentsTransData Nexus · Indian Customs Data

Top Fluoxetine Exporters from India — Ranked by Export Value

SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED is the leading fluoxetine exporter from India, holding a 48.4% share of the $235.3M market across 3,702 shipments from 253 exporters. The top 5 suppliers — SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, MICRO LABS LIMITED, AUROBINDO PHARMA LTD, TORRENT PHARMACEUTICALS LTD — collectively control 80.4% of total export value, indicating a highly concentrated market. Individual shares are: SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED (48.4%), INTAS PHARMACEUTICALS LIMITED (12.5%), MICRO LABS LIMITED (11.0%), AUROBINDO PHARMA LTD (4.6%), TORRENT PHARMACEUTICALS LTD (3.8%).

Top Fluoxetine Exporters from India

Ranked by export value · 253 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Fluoxetine Exporters from India — Ranked by Export Value. 253 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Fluoxetine exporters

Certification and compliance status for top Fluoxetine suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Intas Pharmaceuticals Limited	Warning Letter, December	Yes, April 2007	Yes	Not verified	FDA inspection in December 2022 found data falsification at Sanand facility.
Aurobindo Pharma Limited	Warning Letter, May 2011	Yes, March 2024	Yes	Not verified	FDA issued a warning letter in May 2011 for Units III and VI.
Alembic Pharmaceuticals Limited	Approved	Yes	Yes	223	Received multiple FDA approvals between 2024 and 2025.
Dr. Reddy's Laboratories Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified for multiple facilities.
Cipla Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified for multiple facilities.
Macleods Pharmaceuticals Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified for multiple facilities.
Torrent Pharmaceuticals Limited	Approved	Yes	Yes	Not verified	WHO-GMP certified for multiple facilities.
APL Healthcare Limited	Approved	Yes, March 2024	Yes	Not verified	WHO-GMP compliance accepted in March 2024.

TransData Nexus reviewed the regulatory standing of 8 leading Fluoxetine exporters from India. 6 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Fluoxetine sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, which are involved in the production of active pharmaceutical ingredients (APIs) and finished formulations. Hyderabad's infrastructure supports large-scale manufacturing, making it a critical node in the supply chain for bulk drugs, including Fluoxetine.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical manufacturing capabilities, particularly in formulations. Companies like Alembic Pharmaceuticals, headquartered in Vadodara, have a significant presence in this region. Alembic Pharmaceuticals is known for producing a range of pharmaceutical products, including Fluoxetine. The region's well-established infrastructure and proximity to major ports facilitate efficient export operations.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt in Maharashtra serves as a powerhouse of the Indian pharmaceutical industry, contributing approximately 25-30% of the country's total pharmaceutical output. This region houses the headquarters of industry giants like Cipla and Sun Pharma, serving as a central hub for corporate functions, regulatory affairs, marketing, and R&D. Its strategic location and well-developed infrastructure make it a pivotal gateway for pharmaceutical exports, including Fluoxetine.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Fluoxetine exporters from India

September 2022

M&A

Torrent Pharmaceuticals Ltd — Torrent Pharmaceuticals acquires Curatio Healthcare

In September 2022, Torrent Pharmaceuticals Ltd acquired Curatio Healthcare, a skincare manufacturer, for ₹2,000 crores. - IMPACT: This acquisition is expected to diversify Torrent's product portfolio, potentially influencing its strategic focus and resource allocation, which may indirectly affect its Fluoxetine export operations.

Impact: This acquisition is expected to diversify Torrent's product portfolio, potentially influencing its strategic focus and resource allocation, which may indirectly affect its Fluoxetine export operations.

Early 2025

M&A

Aurobindo Pharma Ltd — Aurobindo Pharma acquires remaining stake in GLS Pharma

In early 2025, Aurobindo Pharma Ltd completed the acquisition of the remaining 49% stake in GLS Pharma, a Hyderabad-based oncology company, thereby gaining full ownership. - IMPACT: This consolidation enhances Aurobindo's oncology capabilities, potentially leading to a strategic shift that may impact its focus on Fluoxetine exports.

Impact: This consolidation enhances Aurobindo's oncology capabilities, potentially leading to a strategic shift that may impact its focus on Fluoxetine exports.

Common Questions — Fluoxetine Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which fluoxetine supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED leads with 99 recorded shipments worth $113.8M. INTAS PHARMACEUTICALS LIMITED (97 shipments) and MICRO LABS LIMITED (154 shipments) are also established high-volume exporters.

Q How many fluoxetine manufacturers are there in India?

India has 253 active fluoxetine exporters with a combined export market of $235.3M across 3,702 shipments to 101 countries. The top 5 suppliers hold 80.4% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for fluoxetine from India?

Average FOB unit price: $18.42 per unit, ranging from $0.00 to $48554.14. Average shipment value: $63.6K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fluoxetine

Fluoxetine

Who Exports Fluoxetine from India — 253 Suppliers Behind a $235.3M Market

Top Fluoxetine Exporters from India — Ranked by Export Value

Top Fluoxetine Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Torrent Pharmaceuticals Ltd — Torrent Pharmaceuticals acquires Curatio Healthcare

Aurobindo Pharma Ltd — Aurobindo Pharma acquires remaining stake in GLS Pharma

Common Questions — Fluoxetine Suppliers from India

Q Which fluoxetine supplier from India is the most reliable for bulk orders?

Q How many fluoxetine manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for fluoxetine from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Torrent Pharmaceuticals Ltd — Aman Mehta appointed Managing Director of Torrent Pharma

Analysis Methodology